Next Article in Journal
Measuring Health-Related Quality of Life in Young Children: How Far Have We Come?
Previous Article in Journal
From Investigational Product to Active Reference: Evolution of Oral Aumatriptan Efficacy versus Placebo for the Treatment of Acute Migraine Episodes and Potential Impact in Comparative Analyses
 
 
Journal of Market Access & Health Policy (JMAHP) is published by MDPI from Volume 12 Issue 1 (2024). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Taylor & Francis.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Management and Clinical Practice of Multiple Face and Scalp Actinic Keratosis in France

by
Jacques Savary
1,
Marie Christelle Tine
2,*,
Anne Caroline Weber
3 and
Julie Dorey
3
1
Galderma International, Dermatology Clinic, Paris, France
2
Galderma France, Tour Europlaza la Défense, Paris, France
3
Creativ-Ceutical, Paris, France
*
Author to whom correspondence should be addressed.
J. Mark. Access Health Policy 2019, 7(1), 1605787; https://doi.org/10.1080/20016689.2019.1605787
Submission received: 10 January 2019 / Revised: 2 April 2019 / Accepted: 8 April 2019 / Published: 14 May 2019

Abstract

Background: Actinic keratosis (AK) is characterized by the occurrence of thick and scaly skin areas caused by damage from ultraviolet radiation. The management of AK aims to reduce lesions and prevent their recurrence by regular monitoring. French guidelines, last updated in 2009, reflect European guidelines for the management of face and scalp AK. However, they do not address all current, available options. Objective: To assess the management of face and scalp AK in French clinical practice. Methods: A two-part online questionnaire comprising a survey among French dermatologists and an analysis of patient medical records was performed to describe AK patients treated with topical therapy, patients’ profiles, and characteristics of the affected lesion areas. Results: Decisions for topical treatments for face and scalp AK made by dermatologists were mainly driven by the lesion size. According to the last 10 patients they have seen, dermatologists were prescribing physical therapy in 53% of the cases, a combination of topical and physical therapy in 27% and topical only in 20%. Patient records revealed the average surface area targeted for treatment was 139 ± 113 cm2. Conclusions: Discrepancies between the guidelines on the treatment of face and scalp AK and clinical practice exist. Further research may help to standardize the treatment.
Keywords: actinic keratosis; face and scalp; photodynamic therapy; topical treatments; cryotherapy; cancerization zone actinic keratosis; face and scalp; photodynamic therapy; topical treatments; cryotherapy; cancerization zone

Share and Cite

MDPI and ACS Style

Savary, J.; Tine, M.C.; Weber, A.C.; Dorey, J. Management and Clinical Practice of Multiple Face and Scalp Actinic Keratosis in France. J. Mark. Access Health Policy 2019, 7, 1605787. https://doi.org/10.1080/20016689.2019.1605787

AMA Style

Savary J, Tine MC, Weber AC, Dorey J. Management and Clinical Practice of Multiple Face and Scalp Actinic Keratosis in France. Journal of Market Access & Health Policy. 2019; 7(1):1605787. https://doi.org/10.1080/20016689.2019.1605787

Chicago/Turabian Style

Savary, Jacques, Marie Christelle Tine, Anne Caroline Weber, and Julie Dorey. 2019. "Management and Clinical Practice of Multiple Face and Scalp Actinic Keratosis in France" Journal of Market Access & Health Policy 7, no. 1: 1605787. https://doi.org/10.1080/20016689.2019.1605787

Article Metrics

Back to TopTop